NCT01098526
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Clinical trial condition
HIV Infections
Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.
1,675 public trials
170 recruiting studies
HIV Infections trial results
NCT02571504
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cognition Disorders, +19 more
- Locations
-
- Montreal Neurological Institute and Hospital (McGill University) Montreal, Quebec, Canada
NCT01594632
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Profamilia Santo Domingo, Dominican Republic
Completed
Evaluation of a Peer Education Program to Promote Family Planning Among Female Sex Workers in Kenya
NCT01957813
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- APHIA Plus HIV Prevention Drop-in Centers Naivasha, Rift Valley Province, Kenya
- APHIA Plus HIV Prevention Drop-in Centers Nanyuki, Rift Valley, Kenya
NCT02008526
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- Friends Community Center, a division of Friends Research Institute, Inc., Los Angeles, CA 90028 Los Angeles, California, United States
NCT02666053
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT01101893
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT02095886
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom
Completed
Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults
NCT02346084
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Magee Women's Hospital of UPMC Pittsburgh, Pennsylvania, United States